Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Point-of-care test guided oral corticosteroid treatment in young children with expiratory breathing difficulty
2021-006050-31Phase 4Active
- Sponsor
- University of Oulu
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of prednisolone in chronic bronchitis (CB) and Acute expiratory dyspnea, sponsored by University of Oulu. Primary endpoint: Duration of hospital care. Started Dec 2021; status: active.
02
Drugs
prednisolone
03
Conditions
chronic bronchitis (CB)Acute expiratory dyspnea
Beyond the preview
Go deeper on 2021-006050-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006050-31.